NASDAQ: CAPRRUSSELL2000
Capricor Therapeutics, Inc.
Healthcare · Biotechnology · Headquartered in San Diego, US
Price
Loading chart…
Overview
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
History & business model
This section is waiting to be written.
InvestWiki is community-edited. Contribute a plain-English history of Capricor Therapeutics, Inc., its business model, key products, and controversies.